Rexgenero

45 Pont Street
London
SW1X 0BD
United Kingdom

Tel: +44-0-203-709-1969

Email: info@rexgenero.com

Show jobs for this employer

About Rexgenero

Rexgenero is a leading regenerative medicine company and developer of advanced cell-based therapeutics for the treatment of serious diseases that are poorly treated with existing therapies. We are conducting clinical trials with our stem cell therapies with the intention of obtaining marketing authorization in Europe the United States and other markets.
YEAR FOUNDED:
February 6, 2015
LEADERSHIP:
Chairman: Gaby Salem
Vice Chairman: Vicente Sáez González
CEO: Joe Dupere
COO: Edwin Wagena
VP, Manufacturing and Research & Development: Liesbeth de Jong
VP, Clinical and Regulatory Development: Karen Reitsma
TECHNOLOGY:
Please click here for Rexgenero's technology.
PIPELINE:
Please click here for Rexgenero's pipeline.

10 articles with Rexgenero